Literature DB >> 11413341

Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

A Deora1, L Ratner.   

Abstract

Viral protein U (Vpu) is a 17-kDa phosphoprotein that enhances the release of viral particles from human immunodeficiency virus type 1-infected cells. This study shows that the effect of Vpu on efficient particle release depends on the rate of cell proliferation. Cells arrested by contact inhibition, chemical arresting agents, or terminal differentiation (i.e., macrophages) all exhibited a striking dependence on Vpu for efficient particle release, as shown by examination of particle production from transfections with full-length clones, infections, and the vaccinia virus expression system. In contrast, actively proliferating cells did not exhibit enhanced particle release with Vpu expression. This study demonstrates the necessity of Vpu for efficient viral particle release from quiescent cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413341      PMCID: PMC114397          DOI: 10.1128/JVI.75.14.6714-6718.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.

Authors:  A Deora; P Spearman; L Ratner
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

2.  CD3delta couples T-cell receptor signalling to ERK activation and thymocyte positive selection.

Authors:  P Delgado; E Fernández; V Dave; D Kappes; B Alarcón
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

3.  Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants.

Authors:  P Westervelt; T Henkel; D B Trowbridge; J Orenstein; J Heuser; H E Gendelman; L Ratner
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Authors:  D H Nguyen; J E Hildreth
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.

Authors:  P A Luciw; C P Mandell; S Himathongkham; J Li; T A Low; K A Schmidt; K E Shaw; C Cheng-Mayer
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

6.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  Relationship between productive HIV-1 infection of macrophages and CCR5 utilization.

Authors:  C S Hung; S Pontow; L Ratner
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

8.  Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes.

Authors:  J M Carr; H Hocking; P Li; C J Burrell
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

9.  Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains.

Authors:  E B Babiychuk; A Draeger
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

10.  Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor.

Authors:  P W Janes; S C Ley; A I Magee
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  12 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Macrophages archive HIV-1 virions for dissemination in trans.

Authors:  Natalia Sharova; Catherine Swingler; Mark Sharkey; Mario Stevenson
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

Review 3.  HIV accessory proteins and surviving the host cell.

Authors:  Jenny L Anderson; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

4.  Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.

Authors:  Beth Noble; Paolo Abada; Juan Nunez-Iglesias; Paula M Cannon
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.

Authors:  Gabriela Khoury; Gary Ewart; Carolyn Luscombe; Michelle Miller; John Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

6.  Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Authors:  Paolo Abada; Beth Noble; Paula M Cannon
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.

Authors:  Andrés Finzi; Alexandre Orthwein; Johanne Mercier; Eric A Cohen
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

8.  Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release.

Authors:  Aneeza Salim; Lee Ratner
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

9.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

10.  Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.

Authors:  Emilie Estrabaud; Erwann Le Rouzic; Sandra Lopez-Vergès; Marina Morel; Nadia Belaïdouni; Richard Benarous; Catherine Transy; Clarisse Berlioz-Torrent; Florence Margottin-Goguet
Journal:  PLoS Pathog       Date:  2007-07-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.